Actelion; 2’-Bipyrimidin)-4-Yl)-Enoxy)(; Benzenesulfonamide,4-(1,1-Dimethylethyl)-N-(6-(2-Hydroxyethoxy)-5-(2-Methoxyph; 4-(Tert-Butyl)-N-(6-(2-Hydroxyethoxy)-5-(2-Methoxyphenoxy)-[2,2'-Bipyrimidin]-4-Yl)Benzenesulf; Bosentan Impurity

Brief Introduction

A mixed endothelin receptor antagonist. Used as a vasodilator. Antihypertensive.

Dabigatran

MSDS

CAS:211914-51-1

Molecular Formula:C25H25N7O3

Alias

More Information

Dabigatran (Bibr 953); 3-[[2-[(4-Carbamimidoylanilino)Methyl]-1-Methylbenzimidazole-5-Carbonyl]-Pyridin-2-Ylamino]Propanoic Acid; Unii-I0Vm4M70Gc; Bibr 953,Dabigatran,Bibr953; Bibr-953; Bibr 953Zw; Bibr 953 (Dabigatran,Pradaxa); 3-[[2-[[(4-Carbamimidoylphenyl)Amino]Methyl]-1-Met; Bibr 953(Dabigatran); N-[[2-[[[4-(Aminoiminomethyl)Phenyl]Amino]Methyl]-1-Methyl-1H-Benzo[D]Imidazol-5-Yl]Carbonyl]-N-Pyridin-2-Yl-Beta-Alanine; N-[(2-{[(4-Carbamimidoylphenyl)Amino]Methyl}-1-Methyl-1Hbenzimidazol-; 5-Yl)Carbonyl]-N-Pyridin-2-Yl-Beta-Alanine; Bibr 953 (Dabigatran, Pradaxa); 3-[[2-[[(4-Carbamimidoylphenyl)Amino]Methyl]-1-Methyl-Benzoimidazole-5-Carbonyl]-Pyridin-2-Yl-Amino]; Bib-953

Brief Introduction

Dabigatran is another new oral anticoagulant drug approved by the US Food and Drug Administration for the prevention of stroke and embolism in non valvular atrial fibrillation patients, following warfarin. It is a non peptide thrombin inhibitor and a significant milestone in the field of anticoagulant therapy and potential lethal thrombus prevention.

Ferrous Carbonate

MSDS

CAS:563-71-3

Molecular Formula:CFeO3

Alias

More Information

Iron II Carbonate; Ferrous Monocarbonate; Iron Carbonate; Iron(2+),Carbonate; Blaud'S Mass; Carbonicacid,Iron(2+)Salt(1:1)

Brief Introduction

Feed grade ferrous carbonate is used as a supplement of iron in feed. Ferrous carbonate can also be used as food additives, pigments, raw materials for electronic industry and hydrogen sulfide deodorant.

Sarpogrelate

CAS:125926-17-2

Molecular Formula:C24H31NO6

Alias

More Information

(+/-)-2-(Dimethylamino)-1-{(O-(M-Methoxyphenethyl)Phenoxy)Methyl}Ethyl Hydrogen Succinate; Butanedioic Acid, Mono[2-(Dimethylamino)-1-[[2-[2-(3-Methoxyphenyl)Ethyl]Phenoxy]Methyl]Ethyl] Ester (9Ci); 4-[1-(Dimethylamino)-3-[2-[2-(3-Methoxyphenyl)Ethyl]Phenoxy]Propan-2-Yl]Oxy-4-Oxobutanoic Acid; Sapogrelate; Butanedioic Acid, 1-[2-(Dimethylamino)-1-[[2-[2-(3-Methoxyphenyl)Ethyl]Phenoxy]Methyl]Ethyl] Ester; Sarpogrelate;; Sarpogrelate [INN];

Brief Introduction

Blood system drugs > anticoagulants and antiplatelet drugs

Clevidipine

CAS:167221-71-8

Molecular Formula:C21H23Cl2NO6

Alias

More Information

Clevidipine Butyrate; Cleviprex; Clevelox; Methyl (1-Oxobutoxy)Methyl 4-(2,3-Dichlorophenyl)-1,4-Dihydro-2,6-dime thyl-3,5-Pyridinedicarboxylate; 3,5-Pyridinedicarboxylic acid, 4-(2,3-Dichlorophenyl)-1,4-Dihydro-2,6-Dimethyl-, 3-Methyl 5-[(1-Oxobutoxy)Methyl] Ester

Brief Introduction

Clevidipine is an innovative injectable antihypertensive drug, which can be used to treat acute hypertension for 72 hours. It can be used when oral drugs are ineffective or inconvenient for patients to use oral drugs, and its effect is rapid. Unlike the existing hypertension drugs metabolized through the kidney or liver, lovidipine butyrate is metabolized in the blood and will not accumulate in the body. It is especially suitable for patients with advanced organ damage.

1
···
9
10
11
12
13
14
15
16
17

Inquiry (

/ 10

)

Clear All